Lucid Diagnostics Inc.

NASDAQ: LUCD · Real-Time Price · USD
1.01
0.03 (2.95%)
At close: Aug 15, 2025, 12:52 PM

Lucid Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
4.35M 2.43M 377K 500K
Cost of Revenue
8.27M 8.48M 3.61M 585K
Gross Profit
-3.92M -6.05M -3.24M -85K
Operating Income
-46.05M -48.48M -56.17M -27.42M
Interest Income
322K 424K 88K n/a
Pretax Income
-45.53M -52.67M -56.17M -28.08M
Net Income
-45.53M -52.67M -56.17M -28.08M
Selling & General & Admin
36.62B 35.66M 39.82M 18.04M
Research & Development
5.99M 7.25M 11.47M 9.3M
Other Expenses
-36.58B -478K 1.65M n/a
Operating Expenses
42.13M 42.43M 52.93M 27.33M
Interest Expense
26K 416K 8K 659K
Selling & Marketing Expenses
16.46B 16.4M 16.13M 5.26M
Cost & Expenses
50.4M 50.91M 56.55M 27.92M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
50.52M 41.76M 36.17M 36.06M
Shares Outstanding (Diluted)
50.52M 41.76M 36.17M 36.06M
EPS (Basic)
-1.05 -1.26 -1.55 -0.78
EPS (Diluted)
-1.05 -1.26 -1.55 -0.78
EBITDA
-44.34M -49.75M -54.23M -27.41M
EBIT
-45.5M -52.25M -56.17M -27.42M
Depreciation & Amortization
1.17M 2.5M 1.94M 4K